Aomine Y, Shimo Y, Sakurai K, Abe M, Macpherson T, Ozawa T
J Neurochem. 2024; 169(1):e16227.
PMID: 39289039
PMC: 11658186.
DOI: 10.1111/jnc.16227.
Singh N, Wanjari A, Sinha A
Cureus. 2023; 15(11):e49162.
PMID: 38130519
PMC: 10733894.
DOI: 10.7759/cureus.49162.
Kamalasekaran K, Magesh V, Atchudan R, Arya S, K Sundramoorthy A
Biosensors (Basel). 2023; 13(9).
PMID: 37754073
PMC: 10527255.
DOI: 10.3390/bios13090839.
Deb M, Baruah P
Top Curr Chem (Cham). 2023; 381(4):14.
PMID: 37131054
DOI: 10.1007/s41061-023-00424-x.
Prommaban A, Kheawfu K, Chittasupho C, Sirilun S, Hemsuwimon K, Chaiyana W
Evid Based Complement Alternat Med. 2022; 2022:5761764.
PMID: 36072398
PMC: 9444418.
DOI: 10.1155/2022/5761764.
Tourette disorder and sleep.
Blaty J, DelRosso L
Biomed J. 2022; 45(2):240-249.
PMID: 35031507
PMC: 9250095.
DOI: 10.1016/j.bj.2022.01.002.
New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?.
Beard E, Shahab L, Cummings D, Michie S, West R
CNS Drugs. 2016; 30(10):951-83.
PMID: 27421270
DOI: 10.1007/s40263-016-0362-3.
Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors.
Noda M, Kobayashi A
J Physiol Sci. 2016; 67(1):235-245.
PMID: 27256075
PMC: 5910455.
DOI: 10.1007/s12576-016-0460-5.
Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues.
Patten C, Martin J
Ann Behav Med. 2013; 18(3):190-200.
PMID: 24203772
DOI: 10.1007/BF02883397.
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
Yamin G, Ono K, Inayathullah M, Teplow D
Curr Pharm Des. 2008; 14(30):3231-46.
PMID: 19075703
PMC: 5650911.
DOI: 10.2174/138161208786404137.
Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.
Fowler C, Arends M, Kenny P
Behav Pharmacol. 2008; 19(5-6):461-84.
PMID: 18690103
PMC: 2669417.
DOI: 10.1097/FBP.0b013e32830c360e.
BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.
Bartzokis G
Adolesc Psychiatry. 2008; 29:55-96.
PMID: 18668184
PMC: 2490819.
Caffeine's influence on nicotine's effects in nonsmokers.
Blank M, Kleykamp B, Jennings J, Eissenberg T
Am J Health Behav. 2007; 31(5):473-83.
PMID: 17555378
PMC: 3209967.
DOI: 10.5555/ajhb.2007.31.5.473.
Animal models and treatments for addiction and depression co-morbidity.
Paterson N, Markou A
Neurotox Res. 2007; 11(1):1-32.
PMID: 17449445
DOI: 10.1007/BF03033479.
(E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa.
Spoettl T, Paetzel C, Herfarth H, Bencherif M, Schoelmerich J, Greinwald R
Int J Colorectal Dis. 2006; 22(3):303-12.
PMID: 16715250
DOI: 10.1007/s00384-006-0135-4.
Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model.
Kalra R, Singh S, Pena-Philippides J, Langley R, Razani-Boroujerdi S, Sopori M
Clin Diagn Lab Immunol. 2004; 11(3):563-8.
PMID: 15138183
PMC: 404586.
DOI: 10.1128/CDLI.11.3.563-568.2004.
Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.
Markou A, Kenny P
Neurotox Res. 2003; 4(4):297-313.
PMID: 12829420
DOI: 10.1080/10298420290023963.
Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.
Zoli M, Picciotto M, Ferrari R, Cocchi D, Changeux J
EMBO J. 1999; 18(5):1235-44.
PMID: 10064590
PMC: 1171214.
DOI: 10.1093/emboj/18.5.1235.
Effects of transdermal nicotine on lower esophageal sphincter and esophageal motility.
Kadakia S, De La Baume H, Shaffer R
Dig Dis Sci. 1996; 41(11):2130-4.
PMID: 8943963
DOI: 10.1007/BF02071391.
Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.
Schneider N, Lunell E, Olmstead R, Fagerstrom K
Clin Pharmacokinet. 1996; 31(1):65-80.
PMID: 8827400
DOI: 10.2165/00003088-199631010-00005.